1.
|
Phase: Phase II, Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: IUMC-851130, NCI-T85-0250R, T85-0250
|
|
2.
|
Phase: Phase II, Phase I Type: Treatment Status: Completed Age: 18 to 75 Sponsor: NCI Protocol IDs: IUMC-890117, NCI-T88-0075O, T88-0075
|
|
3.
|
Phase: Phase II, Phase I Type: Treatment Status: Completed Age: 15 and over Sponsor: NCI Protocol IDs: MDA-DM-88108, NCI-T88-0198C, T88-0198
|
|
4.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 to 80 Sponsor: NCI Protocol IDs: BUMC-3333, NCI-T90-0213O, T90-0213
|
|
5.
|
Phase: Phase II Type: Treatment Status: Closed Age: 15 and over Sponsor: NCI Protocol IDs: MDA-DM-8420, NCI-T84-0369D, T84-0369
|
|
6.
|
Phase: Phase II Type: Treatment Status: Completed Age: 15 and over Sponsor: NCI Protocol IDs: MDA-DM-8516, NCI-T84-0421C, T84-0421
|
|
7.
|
Phase: Phase II Type: Treatment Status: Completed Age: no age specified Sponsor: Protocol IDs: MAOP-8185
|
|
8.
|
Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: CAN-NCIC-IND11, NCI-T85-0019W, T85-0019, IND11
|
|
9.
|
Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: CAN-NCIC-IND9, NCI-T85-0018W, T85-0018, IND9
|
|
10.
|
Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: CAN-NCIC-IND10, NCI-T85-0101W, T85-0101, IND10
|
|
11.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Protocol IDs: CAN-NCIC-IND54, NCI-T90-0007O, T90-0007, IND54
|
|
12.
|
Phase: Phase II Type: Treatment Status: Closed Age: 15 and over Sponsor: NCI Protocol IDs: UARK-92016, NCI-T92-0173O, T92-0173
|
|
13.
|
Phase: Phase I Type: Treatment Status: Closed Age: over 18 Sponsor: NCI Protocol IDs: MSKCC-8367R, NCI-T83-1117W, T83-1117
|
|
14.
|
Phase: Phase I Type: Treatment Status: Completed Age: over 18 Sponsor: Protocol IDs: NCI-83-C-31, NCI-MB-CPB-174, NCI-W83-0447, W83-0447
|
|
15.
|
Phase: Phase I Type: Treatment Status: Closed Age: over 18 Sponsor: Protocol IDs: NCI-W82-1515, CTEPIS-0080, W82-1515
|
|
16.
|
Phase: Phase I Type: Treatment Status: Closed Age: 14 and over Sponsor: Protocol IDs: NCI-W83-0251
|
|
17.
|
Phase: Phase I Type: Treatment Status: Completed Age: under 18 Sponsor: Protocol IDs: NCI-83-C-38A, CCG-094, NCI-W83-0323, W83-0323
|
|
18.
|
Phase: Phase I Type: Treatment Status: Closed Age: 16 and over Sponsor: NCI Protocol IDs: NCI-W83-0339, CAN-NCIC-OTT-8207
|
|
19.
|
Phase: Phase I Type: Treatment Status: Closed Age: over 18 Sponsor: NCI Protocol IDs: MAYO-830102, NCI-T83-1072W
|
|
20.
|
Phase: Phase I Type: Treatment Status: Closed Age: 16 and over Sponsor: Protocol IDs: WCCC-CO-8295, NCI-W83-0581
|
|
21.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: UTHSC-83405193, NCI-T84-0351W, T84-0351
|
|
22.
|
Phase: Phase I Type: Treatment Status: Closed Age: over 18 Sponsor: NCI Protocol IDs: CWRCC-ICC-1989, NCI-T88-0235D, T88-0235
|
|
23.
|
Phase: Phase I Type: Treatment Status: Completed Age: 21 and under Sponsor: NCI Protocol IDs: POG-9370
|